90% of the posters here are jerkofs.Novartis is the #1 CF drug and Arikace will NEVER get a NICE recc from the EU. So first find out what NICE is,then find out how much Insmed THINKS they can sell this bong for.
The potty inhaler did get NICE from Europe but Novartis have to sell at a discount.Novartis big bad pharmacuticle company.They got ways to put big pressure on da FDA.Any one ever see that bong used? Only once a day but twice the tyme of powder so dat even steven
You are not allowed to discuss earnings or anything else material that could move the share price before earnings are are released. That's why they have an earnings release. As an example, let's say they cut another licensing deal this quarter that will show up in their earnings. This cannot be disclosed this close to earnings.